Engineered Host Cells for Selective D-Ribulose-to-Ribitol Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing host cells are inefficient in converting D-ribulose to ribitol and often divert the conversion to other molecules like D-arabitol, limiting the production yield of ribitol and its derivatives.
Innovation Solution
Engineered host cells with heterologous nucleic acid sequences encoding polypeptides that preferentially convert D-ribulose to ribitol using NADPH as a cofactor, and modified to reduce or eliminate conversion to other molecules like D-arabitol, using genetic engineering techniques such as homologous recombination and promoter alteration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing host cells are used to convert D-ribulose to ribitol, then some ribitol production occurs, but the conversion efficiency is low and significant amounts of D-ribulose are diverted to other molecules like D-arabitol
Solution Approach 1:
The patent removes or reduces the activity of endogenous enzymes (such as D-arabitol dehydrogenase) that divert D-ribulose away from ribitol production. By taking out these competing enzymatic pathways through gene deletion or inhibition, the substrate flow is redirected exclusively toward ribitol formation, eliminating the loss of D-ribulose to unwanted byproducts.
Solution Approach 2:
The patent introduces heterologous nucleic acid sequences encoding polypeptides with altered cofactor preferences (NADPH-specific ribulose reductases). This parameter change in enzyme specificity ensures that the introduced enzymes preferentially reduce D-ribulose to ribitol using NADPH, while the modified host cell lacks alternative pathways that would consume D-ribulose through different cofactors or enzymes, thereby maximizing ribitol yield.
2Productivity
If heterologous polypeptides with NADPH preference are introduced, then ribitol conversion efficiency increases, but the host cell requires genetic modification which increases complexity
Solution Approach 1:
The patent combines multiple genetic modifications into a single integrated system: introducing heterologous NADPH-specific ribulose reductase genes, deleting or modifying endogenous genes (such as D-arabitol dehydrogenase), and optimizing promoter elements. These separate genetic operations are merged into a unified engineered host cell strain that achieves high ribitol conversion efficiency through coordinated action of multiple modified components.
Solution Approach 2:
The engineered host cell serves multiple functions: it produces D-ribulose from glucose through the pentose phosphate pathway, converts D-ribulose to ribitol with high efficiency using introduced NADPH-specific enzymes, and simultaneously lacks alternative D-ribulose consumption pathways. This multi-functional design allows a single cell strain to achieve both high productivity and pathway specificity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered cells significantly enhance the production of ribitol and its derivatives, achieving yields greater than 95% conversion of D-ribulose to ribitol, facilitating the production of valuable compounds like L-ribulose, L-arabinose, and L-ribose.
Implementation Method 1
a heterologous nucleic acid sequence encoding a polypeptide capable of converting D-ribulose to ribitol with a cofactor preference for NADPH
Data Source
AI summary
The present invention relates to host cells and their use wherein the host cells are capable of producing D-ribulose and incapable of or have a reduced capability of converting D-ribulose to a molecule other than ribitol, wherein the host cells comprise a heterologous nucleic acid sequence encoding a polypeptide capable of converting D-ribulose to ribitol with a cofactor preference for NADPH.